Skip to main content
. 2017 Aug 31;16(5):6558–6569. doi: 10.3892/mmr.2017.7411

Figure 4.

Figure 4.

IB treatment regulated mRNA expression levels of allergic-associated genes. (A-M) The mRNA expression level in nasal mucosa was determined by reverse transcription-quantitative polymerase chain reaction with β-actin as the reference gene. Control: Group A (n=7) and group B (n=8). Model: Group C (n=8), group D (n=10) and group E (n=9). Data are presented as the mean ± standard deviation. *P<0.05 vs. group C following IB treatment; #P<0.05. IB, ipratropium bromide; mRNA, messenger RNA; IL, interleukin; PGDS, prostaglandin D2 synthase; LIF, leukemia inhibitory factor; A20, tumor necrosis factor α-induced protein 3; NR4A1, nuclear receptor subfamily 4, group A, member 1; IFN-γ, interferon-gamma; FoxP3, forkhead box P3.